C12Y 204/01206
Lactosylceramide 1,3-n-acetyl-beta-d-glucosaminyltransferase
Official title: Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (2.4.1.206)
C12Y204/01206 (Lactosylceramide 1,3-n-acetyl-beta-d-glucosaminyltransferase) appears on 1 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 1
- Published applications
- 3
- Assignees
- 2
- Inventors
- 2
- Latest grant
- 29 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Enhancing formation of human milk oligosaccharides (hmos) by modifying lactose import in the cell15 Jan 2026US 2026/0015636 A1Dsm IP Assets B.V.
- Enhancing formation of human milk oligosaccharides (hmos) by modifying lactose import in the cell22 Aug 2024US 2024/0279697 A1Dsm IP Assets B.V.
- Glycan Targets of Serum IgG and IgM Antibodies13 Jun 2024US 2024/0189365 A1Regents of the University of Minnesota
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.